Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Rivera-Caravaca JM, Ding WY, Marin F, Roldan V, Lip GYH; Christina J.-Y. Lee MD, PhD; Christian Torp-Pedersen MD, DMSc. Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients. Eur J Intern Med. 2022 Apr;98:122-124. doi: 10.1016/j.ejim.2021.12.014. Epub 2021 Dec 21. No abstract available. PubMed PMID: 34952769.
AÑO: 2022; IF: 8.0
34952769
Roldan V, Martinez-Montesinos L, Lopez-Galvez R, Garcia-Tomas L, Lip GYH, Rivera-Caravaca JM, Marin F. Relation of the 'Atrial Fibrillation Better Care (ABC) Pathway' to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists. J Pers Med. 2022 Mar 17;12(3):487. doi: 10.3390/jpm12030487. PubMed PMID: 35330486; PubMed Central PMCID: PMC8954236.
AÑO: 2022; IF: 3.508
35330486
Dalby A, Mezzano D, Rivera J, Watson SP, Morgan NV. Introduction of an ancient founder glycoprotein VI mutation into the Chilean population. Blood Adv. 2022 Nov 22;6(22):5866-5869. doi: 10.1182/bloodadvances.2022008531. No abstract available. PubMed PMID: 35994634; PubMed Central PMCID: PMC9647427.
AÑO: 2022; IF: 7.5
35994634
Navarro-Manzano E, Luengo-Gil G, Gonzalez-Conejero R, Garcia-Garre E, Garcia-Martinez E, Garcia-Torralba E, Chaves-Benito A, Vicente V, Ayala de la Pena F. Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer. Cancers (Basel). 2022 May 12;14(10):2390. doi: 10.3390/cancers14102390. PubMed PMID: 35625994; PubMed Central PMCID: PMC9139340.
AÑO: 2022; IF: 6.575
35625994
Bishton M, Marshall S, Harchowal J, Salles G, Golfier C, Tucci A, Fernandez AR, Sanchez Blanco JJ, Bocchia M, Kim S, Lee YN, Zinzani PL. The safety and clinical effectiveness of rapid infusion with CT-P10 in patients with non-Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non-interventional post-authorization safety study in Europe. Hematol Oncol. 2022 Aug;40(3):370-380. doi: 10.1002/hon.2978. Epub 2022 Mar 17. PubMed PMID: 35168291; PubMed Central PMCID: PMC9545983.
AÑO: 2022; IF: 3.3
35168291
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL